Paper
0
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
Authors
Ian Krop,Ingrid Mayer
Vinod Ganju,Maura Dickler,Stephen Johnston,Serafín Morales,Denise Yardley,Bohuslav Melichar,Andres Forero‐Torres,Soo Lee,Richard Boer,Katarína Petráková,Susanne Vallentin,Edith Perez,Martine Piccart,Matthew Ellis,Eric Winer,Steven Gendreau,Mika Derynck,Mark Lackner,Gallia Levy,Jiaheng Qiu,Jing He,Peter Schmid
+22 authors
,Andrés Forero-TorresJournal
Published
May 5, 2016
Show more
Save
Tip0
TipSave